Filtricine
Treating Cancer with Food
Sunnyvale · Founded 2017 · $5.3M raised
- Headquarters
- Sunnyvale
- Founded
- 2017
- Business Model
- B2C
- Website
- filtricine.com
- Total Funding
- $5.3M
- Last Round
- $5.0M SeedAug 2022
- Rounds
- 5
About
Filtricine, Inc. is a clinical-stage biotechnology company developing novel products for cancer care, headquartered in the San Francisco Bay Area of California. The company's proprietary nutrient-deprivation regimen, discovered from founders' research at Stanford University, uses specially formulated meal-replacement foods (soups, shakes, bars) branded Tality to help cancer patients manage their disease, with its lead product currently in clinical studies including a Stanford-sponsored prostate cancer trial.
Summary
Filtricine is a Biotech company based in Sunnyvale, founded in 2017. It has raised $5.3M in total across 5 rounds, most recently a $5.0M Seed round in Aug 2022.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2022
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...